Research and Development (i) Advice and assistance in relation to research and development of Party B;
Promotion and Marketing For the purpose of promotion and marketing, the Borrower hereby authorizes and consents to the reproduction, disclosure and use by the Lenders and the Agent of its name, identifying logo and the Facilities, provided that the amount of Facilities shall not be disclosed. The Borrower acknowledges and agrees that the Lenders shall be entitled to determine, in their sole discretion, whether to use such information; that no compensation will be payable by the Lenders or the Agent in connection therewith; and that the Lenders and the Agent shall have no liability whatsoever to it or any of its employees, officers, directors, affiliates or shareholders in obtaining and using such information as contemplated herein.
Cellular Phone Employer shall provide Employee with a cellular phone for his use in performing his responsibilities with Employer. In the alternative, Employer shall pay Employee’s cellular phone expense.
Conhecimento da Lingua O Contratado, pelo presente instrumento, declara expressamente que tem pleno conhecimento da língua inglesa e que leu, compreendeu e livremente aceitou e concordou com os termos e condições estabelecidas no Plano e no Acordo de Atribuição (“Agreement” xx xxxxxx).
Manufacturing and Marketing Rights The Company has not granted rights to manufacture, produce, assemble, license, market, or sell its products to any other person and is not bound by any agreement that affects the Company's exclusive right to develop, manufacture, assemble, distribute, market, or sell its products.
Regulatory Affairs Development and production of medical products and processes fall under the purview of the Food and Drug Administration (FDA) and research on these products involving animal or human studies is regulated by other laws, directives, and regulations. Project Awards under this Agreement that involve work in support of or related to FDA regulatory approval will address contingencies for Government access to regulatory rights in the event of product development abandonment or failure. Efforts conducted under this OTA shall be done ethically and in accordance with all applicable laws, directives, and regulations. The Government shall ensure performance includes regulatory expertise and guidance for candidate medical countermeasure development efforts:
Clinical Development Licensee will have sole responsibility for and sole decision making over the clinical development of any Product arising from the Research Program in the Field. Notwithstanding the foregoing, if Licensee wishes to conduct clinical development of a Development Candidate at Penn and Penn has the clinical expertise, interest and ability to run such a trial as assessed at Penn’s sole discretion, such a study will be conducted under a separate Clinical Trial Agreement to be negotiated by the Parties prior to initiation of such study. Such separate clinical trial agreement will include a detailed clinical development plan, including costs and time lines for conducting the Clinical Trial.
Xxxxxxx, President Xxxxx X.
Xxxxxxxx, President ACKNOWLEDGED AND ACCEPTED ------------------------- State Street Bank and Trust Company
Xxxxxx, President Name Title Customer Acceptance of Proposal: The above prices, proposal, provisions and conditions are satisfactory and are hereby accepted. Service Provider is authorized to do the work as specified. Payment will be made as described on the terms outlined in this Service Agreement. CUSTOMER BY: Signature Date Name Title APPRISS INC. SERVICE AGREEMENT - EXHIBIT A Customer: Xxxx County Billing Address: Street Address City State Zip Finance Contact: Name Title Telephone: Fax: E-mail: Funding Source: Texas Office of the Attorney General – Grant Administration Division Billing Address: X.X. Xxx 00000 Xxxxxx Xxxxxxx Xxxxxx XX 00000-0000 City State Zip Finance Contact: Xxxxx Xxxxxxxx Name Texas SAVNS Program Manager Title Telephone: 000-000-0000 Fax: 000-000-0000 Date funds to be received from Funding Source: Upon submittal of FY2019 OAG required documentation. Mail payments to: APPRISS INC. 0000 XXXX XXXXXXX XX XXXXX 000 XXXXXXXXXX, XX 00000-0000 Questions and correspondence related to xxxxxxxx and/or payments may be directed to: xxxxxxx@xxxxxxxxxxxxx.xxx Xxxxxxx X. Xxxxxx Appriss Inc. 0000 Xxxx Xxxxxxx Xxxx, Xxxxx 000 Xxxxxxxxxx, XX 00000-0000
